Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
November 7, 2022
A validated UHPLC-MS/MS assay for rapid and sensitive determination of crisaborale in human plasma and its clinico-pharmacokinetic application
Xiangling Feng, Zhijie Deng, Jing Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 20, 2017
Population pharmacokinetics of arginine glutamate in healthy Chinese volunteers
Jing Wang, Heng Zheng, Kun Wang, et al.
Frontiers in Oncology
|
December 20, 2021
Cost-Effectiveness Analysis of Camrelizumab <i>vs.</i> Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Qilin Zhang, Pan Wu, Xucheng He, et al.
Pharmaceutical Biology
|
June 25, 2019
Effects of puerarin on the pharmacokinetics of triptolide in rats
Qingfa Wang, Yanping Wu, Fengting Xiang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 26, 2021
Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer
Xiangling Feng, Yufeng Ding, Peng Zhang, et al.
FEBS Letters
|
February 15, 2011
Candida albicans Zcf37, a zinc finger protein, is required for stabilization of the white state
Huafeng Wang, Wenji Song, Guanghua Huang, et al.
Journal of Clinical Pharmacology
|
August 11, 2023
Therapeutic Drug Monitoring of Imatinib and N-Desmethyl Imatinib in Chronic Myeloid Leukemia Patients Using LC-MS/MS in a Cohort Study
Xiaoxing Huang, Yiwei Liu, Jie Chen, et al.
Cancer Medicine
|
July 24, 2022
Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database
Yamin Shu, Yufeng Ding, Xucheng He, et al.
Frontiers in Pharmacology
|
June 27, 2022
Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Yamin Shu, Yufeng Ding, Yanxin Liu, et al.
Chemico-Biological Interactions
|
October 9, 2017
Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling
Xiaofan Yang, Yufeng Ding, Miao Xiao, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Journal of Pharmaceutical and Biomedical Analysis
|
November 7, 2022
A validated UHPLC-MS/MS assay for rapid and sensitive determination of crisaborale in human plasma and its clinico-pharmacokinetic application
Xiangling Feng, Zhijie Deng, Jing Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
September 20, 2017
Population pharmacokinetics of arginine glutamate in healthy Chinese volunteers
Jing Wang, Heng Zheng, Kun Wang, et al.
Frontiers in Oncology
|
December 20, 2021
Cost-Effectiveness Analysis of Camrelizumab <i>vs.</i> Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Qilin Zhang, Pan Wu, Xucheng He, et al.
Pharmaceutical Biology
|
June 25, 2019
Effects of puerarin on the pharmacokinetics of triptolide in rats
Qingfa Wang, Yanping Wu, Fengting Xiang, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 26, 2021
Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer
Xiangling Feng, Yufeng Ding, Peng Zhang, et al.
FEBS Letters
|
February 15, 2011
Candida albicans Zcf37, a zinc finger protein, is required for stabilization of the white state
Huafeng Wang, Wenji Song, Guanghua Huang, et al.
Journal of Clinical Pharmacology
|
August 11, 2023
Therapeutic Drug Monitoring of Imatinib and N-Desmethyl Imatinib in Chronic Myeloid Leukemia Patients Using LC-MS/MS in a Cohort Study
Xiaoxing Huang, Yiwei Liu, Jie Chen, et al.
Cancer Medicine
|
July 24, 2022
Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database
Yamin Shu, Yufeng Ding, Xucheng He, et al.
Frontiers in Pharmacology
|
June 27, 2022
Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Yamin Shu, Yufeng Ding, Yanxin Liu, et al.
Chemico-Biological Interactions
|
October 9, 2017
Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling
Xiaofan Yang, Yufeng Ding, Miao Xiao, et al.
Page
of 7